Jefferies
Untracked preview. This is not a tracked Signal Bureau entity — the page is generated on request from live coverage search, is not indexed, and carries no editorial curation. Tracked entities live on the Wire.
If Jefferies is on your watch list: what changed in the coverage, what the reporting asserts, and what the crowd is pricing.
What’s changed
- Welspun Corp shares jump 6% after Jefferies initiates coverage with Buy rating. Should you invest? · Economic Times · 2026-09-03
- Jefferies initiates coverage on Leela Hotels with Buy rating, sees 22% upside · Economic Times · 2026-08-31
- Jefferies cuts HDFC Bank price target, retains Buy after CEO exit. Here’s why · Economic Times · 2026-08-31
- HDFC Bank shares gain over 2% as CEO Jagdishan rejects new term; Morgan Stanley, Jefferies, others weigh in · Economic Times · 2026-08-31
- BSE, Groww, Angel One shares rally up to 8% after Sebi’s CAS circular. What did the regulator say? · Economic Times · 2026-09-04
- Akeso, Summit’s ivonescimab extends lives in Keytruda head-to-head trial. What now? · Fierce Pharma · 2026-09-04
What the reporting says
Across 25 tracked stories from 10 outlets, reporting on Jefferies most often describes acquisition (4), launches or releases (2), regulatory approvals (1), IPOs or listings (1), meetings or visits (1), price levels (1).
It shows up alongside Sensex (8).
Two steps out: Brent Crude (through Sensex, 8 shared stories on the weaker link); Disclaimer (through Sensex, 8 shared stories on the weaker link); Fy26 (through Sensex, 8 shared stories on the weaker link); Fy27 (through Sensex, 8 shared stories on the weaker link).
Tracked since Apr 24, with coverage on 11 separate days — concentrated in India South Asia and FDA Decisions.